[A comparative study of the clinical effectiveness of Progestasert and Copper-T-200 (author's transl)].
In a comparative study Progestasert and Copper-T-200 were tested. Progestasert had a significantly higher expulsion rate and required removal due to bleeding, pain or medical reasons. As a consequence, 12 months after insertion the continuation rate of Progestasert was only 66.3% in comparison with 90.4% with Copper-T-200.
D005260:Female; D006801:Humans; D007435:Intrauterine Devices, Copper / Q000592:standards*; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects / Q000592:standards*; D010146:Pain / Q000209:etiology; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D014592:Uterine Hemorrhage / Q000209:etiology
D011374:Progesterone
Vergleich der klinischen Wirksamkeit von Progestasert mit dem Kupfer-T-200.